JK Agri Genetics Limited reported its audited financial results for the quarter and financial year ended 31st March 2026, as approved by the Board of Directors at its meeting held on 8th May 2026. The results, covering both standalone and consolidated performance, reflect a year marked by declining revenues, a wider net loss, and notable tax-related adjustments. The Board also resolved not to recommend any dividend for the financial year 2025-26.

Financial Performance: FY26 vs FY25

On a standalone basis, the company's revenue from operations declined to ₹15,759.33 lacs in FY26 from ₹16,178.73 lacs in FY25. Total income, including other income of ₹701.68 lacs, stood at ₹16,461.01 lacs against ₹16,689.43 lacs in the prior year. Total expenses for the year fell significantly to ₹16,350.47 lacs from ₹18,184.43 lacs, primarily driven by lower employee benefit expenses and a higher inventory build-up. Despite the reduction in expenses, the company reported a net loss of ₹717.47 lacs for FY26, compared to a net loss of ₹260.44 lacs in FY25, impacted by tax-related adjustments including a reversal of Deferred Tax Asset of ₹212.68 lacs and MAT Credit Entitlement of ₹521.01 lacs following the company's adoption of the new tax regime under Section 115BAA of the Income Tax Act, 2025.

The following table summarises the key standalone and consolidated income statement metrics:

Quarterly Performance: Q4 FY26

For the quarter ended 31st March 2026, standalone revenue from operations stood at ₹2,295.85 lacs, compared to ₹2,758.70 lacs in Q4 FY25 and ₹2,362.99 lacs in Q3 FY26. The company reported a standalone net loss of ₹909.86 lacs for Q4 FY26, significantly wider than the net loss of ₹134.81 lacs in Q4 FY25, largely attributable to tax adjustments during the quarter. Basic and diluted EPS for Q4 FY26 stood at ₹(19.62) on a standalone basis.

Exceptional Items and Tax Adjustments

During the year, the company recognised an exceptional loss of ₹84.64 lacs pertaining to increased obligations towards past service cost on gratuity (₹47.94 lacs) and compensated absences (₹36.70 lacs), pursuant to a notification by the Ministry of Labour & Employment on 21st November 2025 regarding four new labour codes. In the previous year, exceptional items had included a net gain of ₹1,248.50 lacs. Additionally, the company's transition to the new tax regime resulted in the reversal of Deferred Tax Asset of ₹212.68 lacs and MAT Credit Entitlement of ₹521.01 lacs during the current quarter and year.

Balance Sheet and Cash Flow Highlights

As at 31st March 2026, total assets on a standalone basis stood at ₹27,221.58 lacs, compared to ₹29,729.78 lacs as at 31st March 2025. Inventories increased to ₹9,809.57 lacs from ₹7,227.42 lacs, while current investments declined to ₹7,291.09 lacs from ₹9,839.88 lacs. Total equity stood at ₹10,035.81 lacs against ₹10,748.54 lacs in the prior year. The following table presents the key cash flow metrics for the year:

Auditor's Report and Emphasis of Matter

The auditors, Lodha & Co LLP, issued an unmodified opinion on both the standalone and consolidated financial results for the quarter and year ended 31st March 2026. However, the auditors drew attention to overdue trade receivables of Rs. 1,823.61 lakhs and a security deposit of Rs. 121.68 lakhs from Rajasthan State Seeds Corporation (RSSC), in respect of which legal proceedings are ongoing. The company's application under Section 34 of the Arbitration and Conciliation Act filed before the Commercial Court, Jaipur was dismissed, following which the company has filed an Objection Application before the High Court of Rajasthan at Jaipur under Section 37 of the Arbitration Act. Management has considered the outstanding amounts as good and recoverable and has not made any provision at this stage. The auditors' opinion was not modified in respect of this matter. It was also noted that JK Agri Research Services Limited ceased to be an associate of the company with effect from 5th March 2026.

JK Agri Genetics has scheduled a Board of Directors meeting for May 8, 2026, to review and approve crucial financial matters for the concluded financial year. The company issued the formal intimation on May 1, 2026, in compliance with regulatory requirements under SEBI listing obligations.

Board Meeting Agenda

The board meeting will address two primary matters of significant importance to shareholders and stakeholders:

Trading Window Restrictions

In accordance with SEBI (Prohibition of Insider Trading) Regulation, 2015, and the company's Code of Conduct for designated persons, JK Agri Genetics has implemented trading window restrictions. The trading window closure and reopening schedule follows regulatory compliance requirements:

The trading window restrictions ensure compliance with insider trading regulations during the period leading up to and following the announcement of financial results. This measure protects market integrity and prevents any potential misuse of unpublished price-sensitive information.

Regulatory Compliance

The board meeting intimation has been filed under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Anoop Singh Gusain signed the formal communication, ensuring adherence to corporate governance standards and regulatory timelines.

The meeting outcomes, particularly the financial results and any dividend announcement, will be crucial for investors and market participants to assess the company's performance for the financial year ended March 31, 2026.